{"text": "@ScottGottliebMD Curious your thoughts on Brilacidin as a prophylactic and treatment.  Seems to be garnering government lab favor. #COVID19 $IPIX https://t.co/gak25dE1LG", "in_reply_to_user_id": "40156330", "entities": {"urls": [{"start": 146, "end": 169, "url": "https://t.co/gak25dE1LG", "expanded_url": "http://www.ipharminc.com/press-release/2020/5/26/innovation-pharmaceuticals-receives-data-from-public-health-research-institute-showing-brilacidin-inhibits-sars-cov-2-covid-19-in-a-human-cell-line", "display_url": "ipharminc.com/press-release/\u2026", "status": 200, "unwound_url": "http://www.ipharminc.com/press-release/2020/5/26/innovation-pharmaceuticals-receives-data-from-public-health-research-institute-showing-brilacidin-inhibits-sars-cov-2-covid-19-in-a-human-cell-line"}], "mentions": [{"start": 0, "end": 16, "username": "ScottGottliebMD", "id": "40156330"}], "hashtags": [{"start": 131, "end": 139, "tag": "COVID19"}], "annotations": [{"start": 42, "end": 51, "probability": 0.3376, "type": "Organization", "normalized_text": "Brilacidin"}], "cashtags": [{"start": 140, "end": 145, "tag": "IPIX"}]}, "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "id": "1265595482577014785", "conversation_id": "1265303906965491713", "source": "Twitter for iPhone", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "created_at": "2020-05-27T10:47:31.000Z", "referenced_tweets": [{"type": "replied_to", "id": "1265303906965491713"}], "lang": "en", "possibly_sensitive": false, "reply_settings": "everyone", "author_id": "1264897762782580736"}